Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 3,701–3,725 of 7,816 matching trials · page 149 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Promoting Self-determination for Institutionalized Older People Without Decision-making Capacity: Advance Care Planning by Proxy NCT04779684 Advance care planning by proxy for health care proxies of people wi... Runs in: Switzerland · 1 site |
NA other |
COMPLETED | 20 | Ralf J. Jox OTHER |
2023-12-01 |
|
MRI Assessment of Impaired Glucose Metabolism in Alzheimer's Disease NCT05402566 Deuterium metabolic imaging Runs in: Denmark · 1 site |
NA other |
COMPLETED | 21 | University of Aarhus OTHER |
2023-12-01 |
|
Safety, Tolerability and Pharmacokinetics of AD16 Tablets in Adult Healthy Subjects After Single Administration NCT05787028 AD16 5mg、10mg、20mg、30mg、40mg、60mg、80mg; AD16 placebo 5mg、10mg、20mg、... Runs in: China · 1 site |
PHASE1 other |
COMPLETED | 70 | South China Center For Innovative Pharmaceuticals OTHER |
2023-12-01 |
|
The Effect of High Fat Diet on the Pharmacokinetics of AD16 Tablets in Healthy Chinese Adult Subjects NCT05787041 high-fat diet group(AD16 20mg); fasted group(AD16 20mg) Runs in: China · 1 site |
PHASE1 other |
COMPLETED | 16 | South China Center For Innovative Pharmaceuticals OTHER |
2023-12-01 |
|
Safety, Tolerability and Pharmacokinetics of AD16 Tablets After MAD in Healthy Chinese Adult Subjects NCT05806177 AD16 30mg、40mg; AD16 Placebo 30mg、40mg Runs in: China · 1 site |
PHASE1 other |
COMPLETED | 20 | South China Center For Innovative Pharmaceuticals OTHER |
2023-12-01 |
|
Promoting Adaptive Neuroplasticity in Mild Cognitive Impairment NCT02155946 Transcranial direct current stimulation (tDCS) Soterix Medical Inc.... Runs in: United States · 1 site |
NA other |
COMPLETED | 107 | VA Office of Research and Development OTHER_GOV |
2023-11-30 |
|
Dual-task Training for Function in MCI NCT04059705 Dual-Task Training Runs in: United States · 1 site |
NA other |
COMPLETED | 17 | State University of New York at Buffalo OTHER |
2023-11-30 |
|
Effects of the Buddy-Up Dyadic Physical Activity Program on Health Outcomes of Care Dyads of Dementia: A Pilot Study NCT04913818 BUDPA Program; Control arm (Usual care) Runs in: Hong Kong · 1 site |
NA other |
COMPLETED | 40 | The University of Hong Kong OTHER |
2023-11-30 |
|
Management of Depression and Social Isolation in Older Adults With Dementia With Home-based Telehealth Delivered Behavioral Activation + Caregiver Facilitation. NCT04915040 Behavioral Activation for Depression Runs in: United States · 1 site |
NA other |
COMPLETED | 7 | The University of Texas Health Science Center, Houston OTHER |
2023-11-30 |
|
Cognitive Screening Made Easy for PCPs NCT05082883 Risk Assessment Cognitive Screening Runs in: United States · 1 site |
NA other |
COMPLETED | 152 | University of Texas at Austin OTHER |
2023-11-30 |
|
SOcial coNNEction in Long-Term Care Home Residents NCT05315960 Runs in: Canada; United Kingdom · 2 sites |
NA other |
UNKNOWN | 220 | University College, London OTHER |
2023-11-30 |
|
Preclinical Imaging Biomarkers of Alzheimer's Disease Neuropathology in Young Adults With Youth-onset Diabetes: a Proof-of-concept Study NCT05350514 PI-2620 tracer Runs in: United States · 1 site |
NA other |
COMPLETED | 14 | University of Colorado, Denver OTHER |
2023-11-30 |
|
An Innovative Supportive Care Model for Dementia and Traumatic Brain Injury NCT04495686 Telehealth-delivered Care Coordination Program Runs in: United States · 1 site |
NA other |
UNKNOWN | 171 | University of Virginia OTHER |
2023-11-29 |
|
Assessing Clinical Outcomes in Alzheimer's Disease Agitation NCT04797715 AXS-05; Placebo Runs in: Canada; United States · 63 sites |
PHASE3 other |
COMPLETED | 178 | Axsome Therapeutics, Inc. INDUSTRY |
2023-11-29 |
|
Caregiver Solutions for Dementia Patients NCT05888610 Digital Outpost Runs in: United States · 1 site |
NA other |
COMPLETED | 10 | Prepped Health LLC INDUSTRY |
2023-11-29 |
|
Educational Intervention Among Informal Caregivers of Person With Dementia NCT06003647 Educational Intervention |
NA other |
UNKNOWN | 174 | Universiti Putra Malaysia OTHER |
2023-11-29 |
|
Efficacy of Acupuncture in Patients Post-Covid Brain Fog NCT06144320 Acupuncture |
NA other |
UNKNOWN | 40 | China Medical University Hospital OTHER |
2023-11-29 |
|
Identification of Predictors for Early Cognitive Decline in Men NCT03290040 Runs in: Denmark · 1 site |
NA other |
COMPLETED | 564 | Rigshospitalet, Denmark OTHER |
2023-11-28 |
|
The STEP 4Life Trial NCT05069155 Gamification Runs in: United States · 1 site |
NA other |
COMPLETED | 240 | University of Pennsylvania OTHER |
2023-11-28 |
|
CSF1R PET Probe [18F]CSF-23 in Alzheimer's Disease Brain Imaging NCT06148233 [18F]CSF-23 Runs in: China · 1 site |
NA other |
UNKNOWN | 40 | Huashan Hospital OTHER |
2023-11-28 |
|
Effectiveness Study of the Intervention "Stop Sexual Harassment" in Secondary School NCT04716400 Stop sexual harassment Runs in: Norway · 1 site |
NA other |
COMPLETED | 2,037 | NORCE Norwegian Research Centre AS OTHER |
2023-11-27 |
|
Active Navigation Training NCT05768620 CAVE; TAU Runs in: Italy · 1 site |
NA other |
COMPLETED | 32 | Istituto Auxologico Italiano OTHER |
2023-11-27 |
|
Resource Use and Disease Course in Dementia (REDIC) NCT01920100 Runs in: Norway · 3 sites |
NA other |
COMPLETED | 696 | Sykehuset Innlandet HF OTHER |
2023-11-24 |
|
Minds Navigating the Diagnosis of Mild Cognitive Impairment NCT05690243 Group psychotherapy delivered via video telehealth Runs in: United States · 2 sites |
NA other |
UNKNOWN | 160 | Tuscaloosa Research & Education Advancement Corporation OTHER |
2023-11-24 |
|
A Music-Based Mobile App for People Living With Alzheimer's Disease and Related Dementias (ADRD) NCT06140342 Feasibility study of music-based mobile app Runs in: United States · 1 site |
NA other |
UNKNOWN | 20 | Autotune Me LLC OTHER |
2023-11-24 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial